Versor Investments LP Acquires New Stake in HealthEquity, Inc. (NASDAQ:HQY)

Versor Investments LP acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, Holdings Channel.com reports. The firm acquired 9,100 shares of the company’s stock, valued at approximately $873,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wasatch Advisors LP increased its holdings in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the period. Vaughan Nelson Investment Management L.P. increased its holdings in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Barclays PLC increased its holdings in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after purchasing an additional 112,667 shares during the period. Thrivent Financial for Lutherans increased its holdings in HealthEquity by 33.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock worth $24,033,000 after purchasing an additional 73,404 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in HealthEquity during the 3rd quarter worth about $5,675,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday. BTIG Research increased their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, The Goldman Sachs Group assumed coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,000 shares of company stock valued at $3,895,788. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Up 1.4 %

Shares of NASDAQ HQY opened at $107.05 on Friday. The stock has a market cap of $9.28 billion, a PE ratio of 98.21, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The business has a 50-day moving average price of $104.84 and a 200 day moving average price of $93.08.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm earned $0.40 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.